Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | 4,982,706 | reported | 05 Jan 2026 | tx 5+12,355,546 |
| KALA BIO, Inc. | 103,540 | reported | 23 Oct 2025 | tx 44+3,220,289−337,016 |
| Q32 Bio Inc. | 53,521 | reported | 23 Oct 2025 | tx 8+149,426−70,371 |
| Ruthigen, Inc. | 15,000 | reported | 28 Jan 2021 | tx 10+1,208,881 |
| Jade Biosciences, Inc. |
| 12,500 |
| reported |
| 05 Jun 2024 |
| tx 6+195,997 |
| Third Harmonic Bio, Inc. | 0 | reported | 11 Aug 2025 | tx 9+98,997−261,007 |
| Merus N.V. | 0 | reported | 12 Dec 2025 | tx 20+141,382−234,091 |
| Akero Therapeutics, Inc. | 0 | reported | 09 Dec 2025 | tx 15+91,398−249,705 |
| Aimmune Therapeutics, Inc. | 0 | reported | 13 Oct 2020 | tx 19+118,992−258,781 |
| SEPRACOR INC /DE/ | 0 | reported | 20 Oct 2009 | tx 10+399,665−249,665 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jan 2026 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 4,982,706 | 0.00 USD | deriv |
| 12 Dec 2025 | TENDER | Merus N.V. | 73,576 | 97.00 USD | |
| 12 Dec 2025 | OTHER | Merus N.V. | 13,193 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 8,844 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 14,414 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 16,604 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 8,500 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 8,631 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 5,650 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 4,983 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 6,120 | 0.00 USD | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 9,398 | — | |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 15,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 13,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 13,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 70,587 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 11,493 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 15,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 76,227 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 26,000 | — | deriv |
| 23 Oct 2025 | GRANT_AWARD | Q32 Bio Inc. | 53,521 | 0.00 USD | deriv |
| 23 Oct 2025 | SALE | KALA BIO, Inc. | 154,894 | 0.81 USD | |
| 11 Aug 2025 | OTHER | Third Harmonic Bio, Inc. | 128,631 | — | |
| 11 Aug 2025 | OTHER | Third Harmonic Bio, Inc. | 83,296 | 0.00 USD | deriv |
| 24 Jun 2025 | SALE | KALA BIO, Inc. | 13,227 | 4.01 USD |
1 purchase reported after at least 12 months of silence — most recent on 26 Feb 2018.